Key result
OAC for AF in hemodialysis remains controversial due to bleeding risks without adequate thromboembolic protection.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Iara Atié Malan (2022) conducted an editorial in Atrial Fibrillation and Hemodialysis. Oral anticoagulation vs. No anticoagulation was evaluated. The benefit of oral anticoagulation in patients with atrial fibrillation on hemodialysis remains controversial, as it may increase hemorrhagic risk without adequately protecting against thromboembolism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: